AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglinid GM 2mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Ochoa Laboratories Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglinid GM 2mg/500mg/0.3mg Tablet

Diabextril Trio 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabextril Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Voglinid GM 2mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Voglinid GM 2mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Voglinid GM 2mg/500mg/0.3mg tablet whole; avoid chewing, crushing, or fracturing it. Consume the tablet on an empty stomach.

Common Side effects of Voglinid GM 2mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglinid GM 2mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Voglinid GM 2mg/500mg/0.3mg Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

How Voglinid GM 2mg/500mg/0.3mg Tablet works:

Voglinid GM tablets, containing 2mg, 500mg, and 0.3mg of three distinct antidiabetic agents, offer a triple-action approach to blood sugar management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Voglinid GM 2mg/500mg/0.3mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Voglinid GM 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglinid GM 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Voglinid GM 2mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Voglinid GM 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a reduced dose. The medication is contraindicated in those with severe hepatic dysfunction. Physician consultation is advised.

What if you forget to take Voglinid GM 2mg/500mg/0.3mg Tablet :

Should you forget to take your Voglinid GM 2mg/500mg/0.3mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Voglinid GM 2mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglinid GM 2mg/500mg/0.3mg Tablet

Voglinid GM, a tablet containing Glimepiride 2mg, Metformin 500mg, and Voglibose 0.3mg, treats type 2 diabetes mellitus in adults. This combination medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; Metformin reduces liver glucose production and enhances insulin sensitivity; and Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Voglinid GM 2mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, taste changes, flatulence, stomach pain, headache, rash, and respiratory infections.
Voglinid GM 2mg/500mg/0.3mg Tablets are contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Voglinid GM 2mg/500mg/0.3mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglinid GM 2mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglinid GM 2mg/500mg/0.3...
89
MRP 109
18% off